alnylam pharmaceuticals inc
(ALNY:Consolidated Issue Listed on NASDAQ Global Select )
Michael P. Mason
Vice President of Finance and Treasurer, Alnylam Pharmaceuticals, Inc.
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 1 different industries.|
As of Fiscal Year 2014
Mr. Michael P. Mason has been Vice President of Finance and Treasurer at Alnylam Pharmaceuticals, Inc., since February 28, 2011. Mr. Mason served as Corporate Controller of Alnylam Pharmaceuticals, Inc., from December 2005 to February 2011 and also served as its Senior Director of Finance from August 2009 to February 2011 and as Director of Finance from June 2006 to July 2009. From May 2000 to November 2005, Mr. Mason served in several finance and commercial roles at ...
300 Third StreetPhone: 617-551-8200
Cambridge, Massachusetts 02142
Board Members Memberships*There is no Board Members Memberships data available.
|Ali Mortazavi||Chief Executive and Director|
Silence Therapeutics plc
|Mark W. Schwartz Ph.D.||Chief Executive Officer, President, Director and Member of Ad Hoc (Strategy, Pricing, Etc) Committee|
Galena Biopharma, Inc.
|Mark Joseph Murray Ph.D.||Chief Executive Officer, President and Director|
Tekmira Pharmaceuticals Corporation
|Kleanthis G. Xanthopoulos Ph.D.||Chief Executive Officer, President, Principal Financial & Accounting Officer and Director|
Regulus Therapeutics Inc.
|$600.0K||Compensation as of Fiscal Year 2013.|